GBS/CIDP Foundation to Hold 11th International Symposium
NARBERTH, Pa., Sept. 15 /PRNewswire/ -- The GBS/CIDP Foundation International will host its eleventh international symposium on Guillain-Barre Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in King of Prussia, PA, November 5-7, 2010. Over 400 medical professionals, current and former patients, and caregivers from all over the world are expected to attend the three-day event at the Dolce Hotel – Valley Forge.
In addition to general sessions covering the latest developments in current research, diagnosis, treatment and therapies for GBS and CIDP, there will be over twenty workshops offering important current information for attendees.
In conjunction with Wayne State University School of Medicine, the Foundation is offering a course for medical professionals titled, "Inflammatory Neuropathies-the Impact of Clinical Practice on Outcome," on Saturday, November 6th. Wayne State designates this educational activity for a maximum of 6.50 AMA PRA category 1 Credit(s). This course is recommended by the American Academy of Emergency Medicine.
Speakers include prominent neurologists who actively treat GBS and CIDP patients and conduct vital research, leading physicians in rehabilitation medicine and physicians who themselves have had the diseases. The symposium will provide invaluable information and networking opportunities for patients, relatives and caregivers.
GBS is an inflammatory disease of the peripheral nerves and is characterized by the rapid onset of weakness and often paralysis of the legs, arms, breathing muscles and face. CIDP is a rare disease of the peripheral nerves with weakness occurring over two or more months and is characterized by gradually increasing weakness of the legs and, to a less